Document is current
Any future updates will be listed below
-
Authors
Brink, Mirian https://orcid.org/0000-0002-6014-4810
Visser, Otto
Zweegman, Sonja
Sonneveld, Pieter
Broyl, Annemiek
van de Donk, Niels W.C.J.
Dinmohamed, Avinash G. https://orcid.org/0000-0002-4767-6716
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals (funding not relevant for this mansucript, funding not relevant for this mansucript)
Celgene (funding not relevant for this mansucript, funding not relevant for this mansucript)
- License Information
-
More Information
Article History
Received: 11 September 2020
Revised: 23 December 2020
Accepted: 18 January 2021
First Online: 4 February 2021
Conflict of interest
: N.W.C.J.vdD. has received research support from Janssen Pharmaceuticals, AMGEN, Celgene, Novartis, and BMS and serves in advisory boards for Janssen Pharmaceuticals, AMGEN, Celgene, BMS, Takeda, Roche, Novartis, Bayer, and Servier. P.S. has received research support from Janssen Pharmaceuticals, AMGEN, Celgene, Karyopharm, and BMS and serves in advisory boards for Janssen Pharmaceuticals, AMGEN, Celgene, BMS, and Carsgene. S.Z. serves in advisory boards for Celgene, Janssen Pharmaceuticals, Sanofi, Takeda, Amgen, and has received research support from Janssen Pharmaceuticals, Takeda and Celgene. A.B. serves in advisory boards for Janssen Pharmaceuticals, AMGEN, Celgene, BMS, Takeda. The remaining authors declare no conflict of interest.
